Results 21 to 30 of about 192,550 (263)
Plasmids in Clostridium botulinum and related Clostridium species [PDF]
Applied and Environmental Microbiology, 1984 Toxigenic Clostridium botulinum and nontoxigenic C. sporogenes, C. subterminale, and C. botulinum-like organisms from a variety of sources were screened for plasmids. Of the 68 toxigenic C. botulinum isolates, 56% carried one or more plasmids, ranging in mass from 2.1 to 81 megadaltons. Within individual groups (based on the type of neurotoxin produced)
M S, Strom, M W, Eklund, F T, Poysky
openaire +2 more sources
Zhongguo linchuang yanjiuObjective To investigate the status of intestinal flora in malnourished children and its relationship with se.rum inflammatory cytokines and 25-hydroxyvitamin D［25 (OH) D］levels. Methods A total of 126 malnourished children admitted to Ningde Affiliated
ZHENG Jinlu, WANG Jingjing, LI Haiqing, CHEN Xiangjian
doaj +1 more source
Exploitation of food feedstock and waste for production of biobutanol
Czech Journal of Food Sciences, 2009 Nine strains of solventogenic clostridia including the species C. acetobutylicum, C. beijerinckii, C. pasteurianum, and C. saccharoperbutylacetonicum were tested for the solvents production using potato, maize, and sugar beet molasses as substrates.
Petra Patáková +5 more
doaj +1 more source
Clinics in Laboratory Medicine, 2010 Clostridium difficile infections (CDIs) have emerged as one of the principal threats to the health of hospitalized and immunocompromised patients. The importance of C difficile colonization is increasingly recognized not only as a source for false-positive clinical testing but also as a source of new infections within hospitals and other health care ...
openaire +4 more sources
Farm level survey of spore‐forming bacteria on four dairy farms in the Waikato region of New Zealand
MicrobiologyOpen, 2017 The aim of our study was to determine the occurrence and diversity of economically important spore‐forming bacteria in New Zealand dairy farm systems.
Tanushree B. Gupta, Gale Brightwell
doaj +1 more source
Impact of Long-Term Proton Pump Inhibitor Therapy on Gut Microbiota in F344 Rats: Pilot Study
Gut and Liver, 2016 Background/Aims To evaluate changes in gut microbiota composition following long-term proton pump inhibitor (PPI) treatment. Methods : Twenty-four-week-old F344 rats were fed diets with (n=6) or without (n=5) lansoprazole for 50 weeks.
Cheol Min Shin +11 more
doaj +1 more source
Fuels, 2021 The production of butanol, acetone and ethanol by Clostridium acetobutylicum is a biphasic fermentation process. In the first phase the carbohydrate substrate is metabolized to acetic and butyric acid, in the following second phase the product spectrum ...
Katja Karstens +2 more
doaj +1 more source
Gut microbiome and aging—A dynamic interplay of microbes, metabolites, and the immune system
FEBS Letters, EarlyView.Age‐dependent shifts in microbial communities engender shifts in microbial metabolite profiles. These in turn drive shifts in barrier surface permeability of the gut and brain and induce immune activation. When paired with preexisting age‐related chronic inflammation this increases the risk of neuroinflammation and neurodegenerative diseases.
Aaron Mehl, Eran Blacher
wiley +1 more source
The human gut microbiome across the life course
FEBS Letters, EarlyView.Despite significant individual variation and continuous change throughout life, the human gut microbiome follows some life stage‐specific trends. This article provides a brief overview of how gut microbiome composition shifts across different phases of life. Created in BioRender. Özkurt, E. (2026) https://BioRender.com/8q4nrnc.
Alise J. Ponsero +4 more
wiley +1 more source
Dissecting the Ecological Structure of Health and Disease in the Global Gut Microbiome
Advanced Science, EarlyView.We introduce Wiredancer, a framework that identifies three continuous ecological factors of the gut microbiota. These factors exhibit distinct patterns across health and disease, jointly capturing disrupted ecological stability and offering a new perspective for precision diagnostics and therapeutic strategies.
Baoyuan Zhu +19 more
wiley +1 more source